Hyundai Motor India: A Promising Future

CLSA has initiated coverage on Hyundai Motor India with an 'outperform' rating and a target price of Rs 2,155, indicating a potential 22% increase. Analysts are optimistic about the company's aspirational yet affordable car models in India. Despite a current phase of low growth and high utilization, the new plant in Talegaon is expected to halt the market share loss.

Avenue Supermarts (DMart): Exceeding Expectations

Bernstein recommends an 'outperform' for Avenue Supermarts with a target price of Rs 5,800, suggesting a 65% upside. The retail giant has surpassed expectations with its positive quarterly results, and analysts anticipate a modest improvement in same-store sales growth over the next few quarters.

Divis Laboratories: A Buy for Growth

CITI has a 'buy' recommendation on Divis Laboratories, setting a target price of Rs 6,850, which implies a 20% increase. A recent US court ruling has alleviated concerns over the stock, and despite flat third-quarter revenue projections, margins are expected to expand.

Aditya Birla Capital: Upgraded to Overweight

Morgan Stanley has upgraded Aditya Birla Capital to 'overweight' with a target price of Rs 247, reflecting a 45% potential increase. The company's strong funding access and consistent asset quality management are key factors in this optimistic outlook.

Vishal Mega Mart: A Mass Market Leader

Elara Securities has started coverage on Vishal Mega Mart with a 'buy' rating and a target price of Rs 140, indicating a 35% upside. Described as a 'mass market maven', the company's efficient management and operational excellence position it well for aggressive expansion, rivaling market leaders like DMart and Trent.

Disclaimer: The opinions, analyses, and recommendations expressed herein are those of brokerages and do not reflect the views of The Times of India. Always consult with a qualified investment advisor or financial planner before making any investment decisions.